Study Highlights New Target for Antidepressant Therapy
By Sharon Kingman
Tuesday, May 7, 2013
LONDON The future development of a new class of antidepressants has edged closer, with the discovery of a molecular pathway that is fundamental to the development of depression. In depression, high levels of stress hormones such as glucocorticoids are linked to a reduced rate by which new brain cells develop a process called neurogenesis.
Note: our contact information has changed
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
© 2013 Thomson Reuters. Reproduction, reposting content is strictly prohibited.
Sign up for Perspectives FREE e-mail newsletter